Eribulin mesylate (E7389): review of efficacy and tolerability in breast, pancreatic, head and neck, and non-small cell lung cancer.

Eribulin mesylate (E7389): review of efficacy and tolerability in breast, pancreatic, head and neck, and non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q38022118
Recent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine originRecent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsPharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial.Emerging mitotic inhibitors for non-small cell carcinoma.Natural product and natural product derived drugs in clinical trials.Anticancer agent-based marine natural products and related compounds.Review on the clinical use of eribulin mesylate for the treatment of breast cancer.An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.
P2860

Eribulin mesylate (E7389): review of efficacy and tolerability in breast, pancreatic, head and neck, and non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q38022118
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Eribulin mesylate (E7389): rev ...... nd non-small cell lung cancer.
@en
type
label
Eribulin mesylate (E7389): rev ...... nd non-small cell lung cancer.
@en
prefLabel
Eribulin mesylate (E7389): rev ...... nd non-small cell lung cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Eribulin mesylate (E7389): rev ...... nd non-small cell lung cancer.
@en
P2093
P304
P31
P356
10.1016/J.CLINTHERA.2012.06.003
P433
P478
P577
P698
P921